Dudediligence.

Amgen Inc

AMGNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$8.50BSep ’24$9.09BDec ’24$8.15BMar ’25$9.18BJun ’25$9.56BSep ’25$9.87BDec ’25$8.62BMar ’26$10.05BJun ’26
Net income, by quarter
$2.83BSep ’24$627.0MDec ’24$1.73BMar ’25$1.43BJun ’25$3.22BSep ’25$1.33BDec ’25$1.82BMar ’26$2.38BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$25.98B$26.32B$28.19B$33.42B$36.75B
Gross profit$19.52B$19.92B$19.74B$20.57B$24.71B
Operating income$7.64B$9.57B$7.90B$7.26B$9.08B
Net income$5.89B$6.55B$6.72B$4.09B$7.71B
Operating cash flow$9.26B$9.72B$8.47B$11.49B$9.96B
Free cash flow$8.38B$8.79B$7.36B$10.39B$8.10B
Cash$7.99B$7.63B$10.94B$11.97B$9.13B
Debt$33.31B$38.95B$64.61B$60.10B$54.60B
Shares outstanding558.3M534.0M535.4M536.9M538.8M